Jujuboside a promotes proliferation and neuronal differentiation of APPswe-overexpressing neural stem cells by activating Wnt/β-catenin signaling pathway

Mobilization of hippocampal neurogenesis has been considered as a potential strategy for the treatment of neurodegenerative diseases, including Alzheimer's disease (AD). In present study, we evaluated both the neuroprotective effects and the effects on the proliferation and differentiation of APP-overexpressing neural stem cells (APP-NSCs) by Jujuboside A (JuA) in vitro. Our results demonstrated that JuA (50 mu M) decreased apoptosis and suppressed oxidative stress damage of APP-NSCs. JuA (50 mu M) upregulated the secretion of brain-derived neurotrophic factor and promoted the proliferation and neuronal differentiation of APP-NSCs. Moreover, JuA (50 mu M) upregulated Wnt-3a and beta-catenin protein expression, and enhanced the expression of downstream genes Ccnd1, Neurod1 and Prox1 . However, XAV-939, an inhibitor of the Wnt/beta-catenin signaling pathway, inhibited these positive effects of JuA. Taken together, these findings suggest that JuA promote proliferation and neuronal differentiation of APP-NSCs partly by activating the Wnt/beta-catenin signaling pathway. We hope that this study will provide a viable strategy for the treatment of AD.

Automated summary

This study demonstrates that Jujuboside A (JuA) has neuroprotective effects, promotes proliferation and neuronal differentiation of APP-overexpressing neural stem cells (APP-NSCs), and activates the Wnt/beta-catenin signaling pathway.